Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) has issued an announcement.
Immuron Limited has announced the application for quotation of 135,800 fully paid ordinary securities on the Australian Securities Exchange (ASX), with an issue date of May 29, 2025. This move is part of previously announced transactions and may enhance the company’s market presence and liquidity, potentially impacting its operations and stakeholder interests positively.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 108,473
Technical Sentiment Signal: Sell
Current Market Cap: A$14.72M
Find detailed analytics on IMC stock on TipRanks’ Stock Analysis page.